This week's FierceLifeSci is brought to you by the FierceBiotech Drug Development Forum.
 

Register today to hear from 70+ biotech industry leading speakers.
2nd Drug Development Forum
BROCHURE | FACULTY | REGISTER

Biopharma companies need to adopt creative deal-making and partnership strategies in order to secure financing during this period of high regulatory scrutiny and shaky IPO markets. The FierceBiotech 2nd Drug Development Forum (September 25–27 in Boston) goes into unprecedented depth on how you can pitch the best partnerships for drug development and licensing while navigating financial and regulatory changes. Don't miss our full two-day track devoted entirely to strategic deal-making!

Anticipate the Responses and Judgments of Venture Capitalists to a Crowded Market

Luba Greenwood
Luba Greenwood,
Vice President, Global Mergers, Acquisitions and Business Development, ROCHE
Eva Jack
Eva Jack,
CBO, MERSANA THERAPEUTICS
Brian Gallagher
Brian Gallagher,
Partner, SR ONE
Rosemary Reilly
Rosemary Reilly,
Partner, WILMERHALE

Enable Flexibility, Creativity, and Independence in Partnerships Between Large and Small Biotech Companies

Michael Bailey
Michael Bailey,
CEO, AVEO ONCOLOGY
Cynthia Schwalm
Cynthia Schwalm,
President, North American Commercial Operations, IPSEN
Rich Murray
Rich Murray,
CEO, JOUNCE THERAPEUTICS
Chandra Ramanathan
Chandra Ramanathan,
Vice President and Head, East Coast Innovation Center, BAYER

Evaluate the Risks and Benefits of Deal Complexity: What Really Generates Value?

Angus Grant
Angus Grant, Corporate Vice President, Business Development, CELGENE
Bruce Goldsmith
Bruce Goldsmith, COO, LYCERA

Secure Funding for Preclinical Companies

David Sherris
David Sherris, CEO, GENADAM THERAPEUTICS
Maria Vilenchik
Maria Vilenchik, CEO, FELICITEX THERAPEUTICS
Nikola Trbovic
Nikola Trbovic, Senior Director, Head of R&D Technology Strategy, Worldwide R&D, PFIZER
Carl Berke
Carl Berke, Partner, PARTNERS HEALTHCARE VENTURES
Kevin Bitterman
Kevin Bitterman, Partner, ATLAS VENTURES
Dennis Ford
Dennis Ford, CEO, LIFE SCIENCE NATION
Richard Anders
Richard Anders, Founder, MASS MEDICAL ANGELS

Pioneer Novel Deal Structures in a Changing Marketplace

Shakti Narayan
Shakti Narayan, Vice President, Head of Transactions, JOHNSON & JOHNSON
Casey Logan
Casey Logan, CBO, TRACON PHARMACEUTICALS

Register today and do not miss out on this one-of-a-kind learning and networking experience! Be sure to use Priority Code C942EM9.

I look forward to seeing you in Boston this fall!

Sincerely,

Matt Greenbaum
Production Team Leader
ExL Events, a division of Questex, LLC

 

SPONSORED BY:

Sponsors
For information on exhibition and sponsorship opportunities, please contact Andrew Sinetar at 212-400-6237 or asinetar@exlevents.com.
Forward this email to a colleague

Copyright © 2017 ExL Events, All rights reserved.
Not Interested in Receiving Further Email Promotion Regarding this Event? Click Here


494 8th Avenue, 4th Floor, New York, NY 10001
Phone: 212-400-6240
Email: info@exlevents.com

Reach 300,000+ subscribers with your own message.
Contact Angelique Alcover at aalcover@fiercemarkets.com or call 202-824-5074.



About this email: In order to receive FierceLifeSci for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceLifeSci . [Click here] to unsubscribe.

FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400 
Washington, DC 20036

.